MARTI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 8.005
EU - Europa 2.878
AS - Asia 1.412
SA - Sud America 17
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 12.335
Nazione #
US - Stati Uniti d'America 7.959
IT - Italia 1.322
CN - Cina 740
UA - Ucraina 506
TR - Turchia 304
DE - Germania 302
GB - Regno Unito 239
SG - Singapore 211
RO - Romania 110
SE - Svezia 106
FI - Finlandia 103
ID - Indonesia 46
FR - Francia 45
PL - Polonia 40
CA - Canada 39
IN - India 24
CZ - Repubblica Ceca 23
BE - Belgio 19
IR - Iran 17
AU - Australia 15
NL - Olanda 15
HK - Hong Kong 14
JP - Giappone 14
RU - Federazione Russa 13
ES - Italia 11
BR - Brasile 9
PK - Pakistan 9
AE - Emirati Arabi Uniti 6
HU - Ungheria 6
VN - Vietnam 6
KR - Corea 4
MY - Malesia 4
PE - Perù 4
PH - Filippine 4
PT - Portogallo 4
CL - Cile 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BD - Bangladesh 2
CH - Svizzera 2
DK - Danimarca 2
EU - Europa 2
GR - Grecia 2
IL - Israele 2
JM - Giamaica 2
LT - Lituania 2
MX - Messico 2
TW - Taiwan 2
BG - Bulgaria 1
CO - Colombia 1
CR - Costa Rica 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
IE - Irlanda 1
KH - Cambogia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 12.335
Città #
Fairfield 1.078
Woodbridge 978
Ashburn 618
Chandler 604
Houston 589
Jacksonville 539
Seattle 410
Ann Arbor 393
Wilmington 388
Cambridge 378
Ferrara 233
Izmir 193
Beijing 192
Princeton 158
Nanjing 141
Milan 139
Shanghai 131
Singapore 122
Boardman 110
San Diego 107
New York 89
Redwood City 68
Bremen 43
Hebei 42
Shenyang 40
Jakarta 38
Falls Church 36
Bologna 35
Los Angeles 33
Rome 32
Warsaw 32
Nanchang 27
Norwalk 27
Tianjin 27
Mountain View 26
Washington 26
Jiaxing 25
San Mateo 22
Changsha 20
Auburn Hills 19
Brno 19
Leawood 18
London 18
Brussels 16
Dearborn 14
Hong Kong 14
Augusta 13
Jinan 13
Ardabil 12
Munich 12
Zhengzhou 12
Cagliari 11
Helsinki 11
Kunming 11
Ottawa 10
Redmond 10
Clifton Park 9
Guangzhou 9
Serra 9
Tappahannock 9
Guarda Veneta 8
Mississauga 8
Taizhou 8
Timisoara 8
Verona 8
Winchester 8
Amsterdam 7
Chicago 7
Florence 7
Indiana 7
Minerbe 7
Naples 7
Ningbo 7
Orange 7
Pune 7
Tokyo 7
Turin 7
Daly City 6
Dong Ket 6
Padova 6
San Jose 6
Adelaide 5
Bandung 5
Dubai 5
Ferrara di Monte Baldo 5
Haikou 5
Hangzhou 5
Hounslow 5
Lahore 5
Lanzhou 5
Mumbai 5
Parma 5
San Francisco 5
Selargius 5
Acton 4
Battipaglia 4
Brescia 4
Brooklyn 4
Caerano di San Marco 4
Castenaso 4
Totale 8.696
Nome #
Effetti acuti di JWH-018 e dei suoi sostituti alogenati sulle funzioni sensori-motorie del topo 533
Autoerotic death: un unusual case of lethal asphyxiophilia associated with autogynephilia 247
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 224
Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence 181
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 178
Forensic DNA phenotyping: prediction of human externally visible traits in missing person identification 173
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 159
Dall’America all’Asia: Salvia divinorum e Mitragyna speciosa 157
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 142
1‐cyclohexyl‐x‐methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice 139
Molecular imaging for the evaluation of drug-–receptor interactions in psycoactive substances of abuse 138
Stimulation OF IN VIVO dopamine transmission and intravenous self-administration in rats and mice by JWH-018, a Spice cannabinoid 136
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 134
The Cathinones MDPV and α-PVP Elicit Different Behavioral and Molecular Effects Following Acute Exposure 131
MDMA alone affects sensorimotor and prepulse inhibition responses in mice and rats: tips in the debate on potential MDMA unsafety in human activity 126
The nociceptin/orphanin FQ receptor antagonist J-113397 and L-DOPA additively attenuate experimental parkinsonism through overinhibition of the nigrothalamic pathway 125
Amantadine attenuates levodopa-induced dyskinesia in mice and rats preventing the accompanying rise in nigral GABA levels 124
Loss of cortical GABA terminals in Unverricht–Lundborg disease 124
Urinary excretion profile of methiopropamine in mice following intraperitoneal administration: A liquid chromatography–tandem mass spectrometry investigation 124
Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111 122
null 121
Pharmacological profile of nociceptin/orphanin FQ receptors regulating 5-hydroxytryptamine release in the mouse neocortex 119
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 119
In vivo evidence for a differential contribution of striatal and nigral D1 and D2 receptors to L-DOPA induced dyskinesia and the accompanying surge of nigral amino acid levels 119
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 115
Antagonism of metabotropic glutamate receptor type 5 attenuates L-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease 113
null 113
Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine 113
Dopamine-nociceptin/orphanin FQ interactions in the substantia nigra reticulata of hemiparkinsonian rats: Involvement of D2/D3 receptors and impact on nigro-thalamic neurons and motor activity 113
Neurological, sensorimotor and cardiorespiratory alterations induced by methoxetamine, ketamine and phencyclidine in mice 113
Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson's disease 112
NMDA and non-NMDA ionotropic glutamate receptors modulate striatal acetylcholine release via pre- and postsynaptic mechanisms 111
null 108
JWH-018 impairs sensorimotor functions in mice 108
Striatal Dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors 107
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. 107
Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptors 107
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 106
Changes of glutamatergic control of striatal acetylcholine release in experimental parkinsonism 105
Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies 105
Cocaine modulates allosteric D2-σ1 receptor-receptor interactions on dopamine and glutamate nerve terminals from rat striatum 105
Differential responsiveness of rat striatal nerve endings to the mitochondrial toxin 3-nitropropionic acid: implications for Huntington’s disease 105
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: An electrophysiological study 103
Pharmacological and genetic evidence for pre- and postsynaptic D2 receptor involvement in motor responses to nociceptin/orphanin FQ receptor ligands 103
Pharmacological profiles of presynaptic nociceptin/orphanin FQ receptors modulating 5-hydroxytryptamine and noradrenaline release in the rat neocortex. 102
Antagonisti dei recettori NOP e loro usi terapeutici 101
Acute and repeated administration of MDPV increases aggressive behavior in mice: forensic implications 101
Presynaptic group I and II metabotropic glutamate receptors oppositely modulate striatal acetylcholine release 100
Identification of MT-45 Metabolites: In Silico Prediction, In Vitro Incubation with Rat Hepatocytes and In Vivo Confirmation 99
Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats 98
Nociceptin/orphanin FQ receptors modulate glutamate extracellular levels in the substantia nigra pars reticulata: A microdialysis study in the awake freely moving rat. 95
null 94
null 92
null 92
Novel Synthetic Opioids: The Pathologist's Point of View 92
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 92
null 91
Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat. 89
null 89
null 88
null 87
L-dopa-induced dyskinesia: beyond an excessive dopamine tone in the striatum 87
null 87
Novel halogenated synthetic cannabinoids impair sensorimotor functions in mice 85
Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin 84
null 84
Differential role of striatal and nigral D1receptors in the expression of L-DOPA induced dyskinesia and its neurochemical correlates 83
Nociceptin/orphanin FQ receptors modulate locomotion and motor cortex excitability in adult Rats 82
null 82
Ayahuasca: il vino dell'anima 82
Un distillato Bohémienne tuttora famoso: l’assenzio 82
Phenotypic effects of chronic and acute use of methiopropamine in a mouse model 82
Cutaneous miRNAs expression in human hanging injuries 82
JWH-018 and its N-pentyl-halogenated derivates impair sensory motor functions in mice. 79
Blockade of nociceptin/orphanin FQ transmission in rat substantia nigra reverses haloperidol-induced akinesia and normalizes nigral glutamate release 78
Pharmacological and behavioral effects of the synthetic cannabinoid AKB48 in rats 76
Nanostructured lipid carriers as delivery systems for parkinson’s therapy 75
Behavioral and neurochemical rewarding properties of a cannabinoid compound of Spice drugs: JWH-018 75
Direct and indirect inhibition by nociceptin/orphanin FQ on noradrenaline release from rodent cerebral cortex in vitro 75
Agonisti dei recettori NOP per il trattamento delle discinesie da levodopa; 74
Reply to "MDPV-induced aggression in humans not established" 74
L-glutamate and gamma-aminobutyric acid efflux from rat cerebrocortical synaptosomes: Modulation by kappa- and mu- but not delta- and opioid receptor like-1 receptors 74
Studio degli effetti acuti e cronici e delle proprietà d’abuso del cannabinoide sintetico JWH-018: un approccio multidisciplinare 73
Droghe da stupro: il GHB ed i suoi analoghi 73
Application of 13 loci STR multiplex for cannabis sativa genotyping 71
Application of 13 loci STR multiplex for the cannabis sativa genotyping 71
Forensic DNA Phenotyping (FDP): A Prediction of Human Externally Visible Traits in Missing Person Identification 70
Synthetic cannabinoid JWH-018 impairs object recognition memory in mice: behavioral and electrophysiological evidence 70
Kindled seizure-evoked somatostatin release in the hippocampus: inhibition by MK-801 68
Regulation of miRNAs as new tool for cutaneous vitality lesions demonstration in ligature marks in deaths by hanging 68
Nociceptin/orphanin FQ receptor antagonists riverse akinesia in rat parkinsonian models 62
Studio multidisciplinare degli effetti farmaco-tossicologici e fisiopatologici di nuove molecole psicoattive sintetiche (novel synthetic drugs, ns-drugs) per comprendere le possibili alterazioni psico-fisiche nei guidatori di autoveicoli 62
Mrna profiling in casework analyses 62
L-DOPA-induced modulation of GABA and glutamate release in the substantia nigra pars reticulata and globus pallidus in a rat model of dyskinesia 61
Reciprocal dopamine-glutamate modulation of release in the basal ganglia 61
Nociceptin/orphanin FQ receptor antagonists as a novel therapeutic approach to Parkinson’s disease: interaction with levodopa 59
Nociceptin/orphanin FQ receptor antagonists reverse parkinsonism in MPTP-treated mice and non-human primates 58
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 58
Neurochemical and behavioral profiling in male and female rats of the psychedelic agent 25I-NBOMe 57
Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesia in a rat model of Parkinson�s Disease 56
Totale 10.511
Categoria #
all - tutte 55.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 671
Totale 56.584


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.379 336 78 65 316 152 252 206 245 229 245 190 65
2020/20212.265 179 137 190 247 165 176 96 283 84 294 271 143
2021/20221.501 79 181 124 52 87 66 99 69 45 105 144 450
2022/20231.602 179 145 81 150 232 177 104 133 226 28 93 54
2023/20241.386 96 105 65 48 123 204 76 107 56 82 77 347
2024/2025188 188 0 0 0 0 0 0 0 0 0 0 0
Totale 12.623